TGF-β blocked cytotoxic T lymphocytes (CTLs) by specifically inhibiting the expression of perforin, granzyme A, granzyme B, Fas ligand, and interferon-γ molecules that are collectively responsible for CTL-mediated tumor cytotoxicity [109]. Here, TGFB1 is linked to neoplasm.